Bausch Health Cos. Inc. and its indirect unit Bausch Health Americas Inc. closed an offering of senior notes worth about $1.5 billion.
Canada's Bausch Health Cos. issued $500 million of its 5.75% senior secured notes due 2027, and Bausch Health Americas offered $1 billion of its 8.50% senior unsecured notes due 2027.
The drugmaker plans to use the proceeds from the offering to repurchase $1.5 billion worth of its outstanding notes and pay related fees and expenses.
The notes to be redeemed include outstanding 5.625% senior notes due 2021, up to $800 million worth of outstanding 5.50% senior notes due 2023 and 5.875% senior notes due 2023.
As part of the repurchase process, the company issued an irrevocable notice of redemption for any and all outstanding 2021 senior note. Bausch Health expects the after-tax impact of these transactions to be neutral to its 2019 adjusted net income.